$BCTX project team announces a major breakthrough: BriaCell's Bria-OTS™ clinical trial has achieved another breakthrough, with patients experiencing sustained complete remission of lung metastases. What does this medical milestone mean? It offers new hope for advanced patients unresponsive to standard therapies. From an investment perspective, clinical results of innovative biopharmaceutical projects are often the key trigger for valuation re-evaluation. The project continues to advance, and the fundamentals are being gradually validated.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 6
  • Repost
  • Share
Comment
0/400
MidnightSnapHuntervip
· 7h ago
Another breakthrough in cancer therapy, late-stage patients have a chance, this is true technological innovation
View OriginalReply0
GasOptimizervip
· 7h ago
Complete remission? That's the real breakthrough, not just superficial numbers on paper.
View OriginalReply0
ProposalDetectivevip
· 7h ago
Lung metastasis sustained complete remission? If this really gets mass-produced and implemented, it would be amazing, but it's still too early to say that now.
View OriginalReply0
MonkeySeeMonkeyDovip
· 7h ago
Complete remission of pulmonary metastasis, which is indeed good. But let's wait for FDA approval first; there are many biotech and pharmaceutical projects with impressive clinical data.
View OriginalReply0
MemeCuratorvip
· 7h ago
Another new breakthrough in tumor therapy, this time it really seems to have some substance.
View OriginalReply0
metaverse_hermitvip
· 7h ago
Bro, is this data real? Why does it always say breakthrough...
View OriginalReply0
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)